Heyu Biological Technology Corporation (HYBT) Research
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease. The company, incorporated in 1987 and headquartered in Xiamen, People's Republic of China, was formerly known as Pacific WebWorks, Inc., before adopting its current name, Heyu Biological Technology Corporation, in June 2018.
Market snapshot
- Symbol
- HYBT
- Price
- $0.35
- Day change
- -41.67%
- Market cap
- $361.4M
- P/E ratio
- 241.19x
- 52-week range
- 0.002-3.4
- Sector
- Healthcare
- Industry
- Medical - Devices
Peer companies
Recent insider activity
- Ang Ban Siong — S-Sale (28328194 shares) on 2023-09-28
- Gao Xingjia — trade (0 shares) on 2023-09-04
- Li Wei — trade (0 shares) on 2023-09-04
- Lin Zengqiang — trade (0 shares) on 2023-09-01
- Lin Zhenzhu — trade (0 shares) on 2023-09-01
Open Heyu Biological Technology Corporation (HYBT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.